๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cholecystokinin Antagonists: Pharmacological and Therapeutic Potential

โœ Scribed by Rosario Herranz

Publisher
John Wiley and Sons
Year
2003
Weight
65 KB
Volume
34
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

โœฆ Synopsis

Abstract

For Abstract see ChemInform Abstract in Full Text.

๐Ÿ“œ SIMILAR VOLUMES

Venlafaxine. Pharmacology and therapeuti
Venlafaxine. Pharmacology and therapeutic potential in the treatment of depression
โœ Frances E. Burnett; Timothy G. Dinan ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 158 KB ๐Ÿ‘ 2 views

Venlafaxine is the ยฎrst available antidepressant of the structurally novel SNRI (serotonin noradrenaline-reuptake inhibitor) class of drugs. It resembles the tricyclics in its ability to inhibit presynaptic reuptake of both serotonin and noradrenaline to a clinically signiยฎcant degree. However, it d

Emerging new chemokine CXCR3 antagonists
Emerging new chemokine CXCR3 antagonists and their potential clinical and therapeutic applications
โœ Shailendra Kapoor ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 47 KB

hospitalized in urban teaching centers (52% versus 41%; P ฯฝ 0.0001). ALI and liver failure 7 occurred in 8.2% and 4.5% of patients, respectively; 1.4% died. ALI (16.7% versus 8.0%; P ฯฝ 0.0001), liver failure (11.4% versus 4.4%; P ฯฝ 0.0001), and death (3.0% versus 1.4%; P ฯญ 0.01), but not transplanta

Sulfamates and Their Therapeutic Potenti
Sulfamates and Their Therapeutic Potential
โœ Jean-Yves Winum; Andrea Scozzafava; Jean-Louis Montero; Claudiu T. Supuran ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons โš– 8 KB